Researchers find possible link between jumping genes and cancerous tumor growth

June 29, 2012 by Bob Yirka report

(Medical Xpress) -- Researchers based out of Harvard and Brigham Young Women’s Hospital have found compelling evidence that suggests “retrotransposon movement in somatic cells” - DNA sequences that jump (make copies of themselves that make their way to other sequences) might be responsible for the growth of some types of cancerous tumors.

The team, as they describe in their paper published in the journal Science, found examples of such in samples taken from several different kinds of in multiple patients.

Jumping genes have been seen in a wide variety of plants and animals but have been thought to be rare in mammals, which of course includes humans. Such jumps are thought to play a role in the evolutionary process because their activity generally results in mutations and thus changes in the plant or animal in which it occurs. The researchers note that the elements necessary for jumping genes are widely known to exist in mammals, including humans, but it was thought that their ability to jump was hampered by physiology.

In this new study, the team looked at five specific kinds of cancer: ovarian, multiple myeloma (a type of white blood cell cancer), colorectal, prostate, and those of the brain. Using a computer software computational method called Tea, for Transposable Element Analysis, they found that the incidence of jumping genes was higher than normal for all of the tumors studied except for those of the brain and blood, suggesting that jumping genes just might play a role in the development of several types of . As part of their findings, they noted that the jumping genes found in cancerous tumors tended to occur in the types of tumors that just happen to mutate in several types of cancers, which include some kinds of genes that are known to be tumor suppressors.

In their research, the team found that some transposable element (TE) insertions seemed to provide a path that led to an environment conducive to tumor growth and that different types of TEs were found in different types of tumors. Specifically, they found that out of 194 insertions, 183 were the so named L1 retrotransposons, 10 were of the Alu variety and just one was an ERV.

Validation testing has shown the Tea software used for testing to be ninety seven percent accurate, though the research team suspects the software likely misses some of the jumping genes due to repeats of the genes that occur in close proximity to one another.

Explore further: Scientists present evidence for groundbreaking evolution theory

More information: Landscape of Somatic Retrotransposition in Human Cancers, Science, DOI: 10.1126/science.1222077 . … 6/27/science.1222077

Related Stories

Scientists present evidence for groundbreaking evolution theory

July 14, 2011
The popular belief among scientists that certain sequences of DNA are relatively unimportant in the evolutionary process has been turned on its head by two Murdoch University researchers.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jun 30, 2012
I wonder if these changes in DNA were measured in typical somatic cells that form the niche for the stem cells or in the stem cells themselves.

Mutations in a stem cell would lead directly to cancerous cell being able to create a tumor around it. Mutations in other-than-stem cell would need to cause the cell to become a "stem" cell from which the whole tumor would form.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.